Relevant bibliographies by topics / Prognosis Serous carcinoma

Contents

  1. Journal articles
  2. Books
  3. Book chapters
  4. Conference papers
  5. Reports

Academic literature on the topic 'Prognosis Serous carcinoma'

Author: Grafiati
Published: 5 June 2025
Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Prognosis Serous carcinoma.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Prognosis Serous carcinoma"

1

Seidman, Jeffrey D., Anna Yemelyanova, Jonathan A. Cosin, Anthony Smith, and Robert J. Kurman. "Survival Rates for International Federation of Gynecology and Obstetrics Stage III Ovarian Carcinoma by Cell Type: A Study of 262 Unselected Patients With Uniform Pathologic Review." International Journal of Gynecologic Cancer 22, no. 3 (2012): 367–71. http://dx.doi.org/10.1097/igc.0b013e31823c6f80.

Full text
Abstract:
ObjectivePublished data are conflicting on the influence of cell type on prognosis in ovarian cancer. The recent separation of low-grade serous carcinoma as a distinctive cell type of ovarian cancer with an indolent behavior, in retrospect, suggests that survival in studies that have not separated this group may be inaccurate.MethodsAn unselected series of 262 International Federation of Gynecology and Obstetrics stage III ovarian carcinomas was studied. Diagnostic classification of each tumor was made with particular attention to recent refinements in cell-type classification. Survival curves
APA, Harvard, Vancouver, ISO, and other styles
2

Dr., Dharani V. C., Manjunath H. K. Dr., Akshatha Basavaraju Dr., et al. "Histomorphological Pattern Analysis of Endometrial Carcinomas in a Tertiary Care Hospital." Advance Research Journal of Multidisciplinary Discoveries 73, no. 1 (2022): 01–07. https://doi.org/10.5281/zenodo.6785687.

Full text
Abstract:
<strong>Background: </strong>Endometrial carcinoma which has various histological types is the commonest invasive cancer of female genital tract. Two general groups of endometrial cancer include Type 1 and Type 2. Type 1 tumors are related to prolonged estrogenic stimulation and include endometrioid type and type 2 includes serous carcinoma, clear cell carcinoma and carcinosarcoma. &nbsp; <strong>Materials and methods</strong>: &nbsp;The present study is a retrospective study conducted in the department of pathology at BGS GIMS from January 2018- January 2021.&nbsp; All the endometrial carcino
APA, Harvard, Vancouver, ISO, and other styles
3

Katagiri, Hiroshi, Kentaro Nakayama, Mohammed Tanjimur Rahman, et al. "Is ATP7B a Predictive Marker in Patients With Ovarian Carcinoma Treated With Platinum-Taxane Combination Chemotherapy?" International Journal of Gynecologic Cancer 23, no. 1 (2013): 60–64. http://dx.doi.org/10.1097/igc.0b013e318275afef.

Full text
Abstract:
ObjectiveThis study examined the prognostic significance of copper-transporting P-type adenosine triphosphatase (ATP7B) expression in patients with ovarian carcinoma treated with platinum-taxane combination chemotherapy.MethodsExpression of ATP7B in ovarian carcinoma was assessed by immunohistochemistry and clinical data collected by retrospective review of medical charts.ResultsOverexpression of ATP7B was identified in 25 (29.1%) of 86 ovarian carcinomas. The frequency of ATP7B expression in clear cell carcinomas was significantly higher than that in serous high-grade carcinomas (P&lt; 0.05).
APA, Harvard, Vancouver, ISO, and other styles
4

Dergham, Ana Paula, Caroline Busatta Vaz de Paula, Seigo Nagashima, Márcia Olandoski, Lucia de Noronha, and Vanessa Santos Sotomaior. "Immunohistochemical Profiling of PD-1, PD-L1, CD8, MSI, and p53 and Prognostic Implications in Advanced Serous Ovarian Carcinoma: A Retrospective Study." Journal of Personalized Medicine 13, no. 7 (2023): 1045. http://dx.doi.org/10.3390/jpm13071045.

Full text
Abstract:
Advanced high-grade serous ovarian carcinoma is a serious malignant neoplasm with a late diagnosis and high mortality rate. Even when treated with standard therapy, such as surgery followed by carboplatin and paclitaxel chemotherapy, the prognosis remains unfavorable. Immunotherapy is a treatment alternative that requires further study. Therefore, we aimed to evaluate the expression of PD-1, PD-L1, CD8, MSI (MLH1, MSH2, MSH6, and PMS2), and p53 in the paraffin samples of high-grade serous ovarian carcinoma. A retrospective study of 28 southern Brazilian patients with advanced serous ovarian ca
APA, Harvard, Vancouver, ISO, and other styles
5

Kenda Šuster, Nataša, Snježana Frković Grazio, Irma Virant-Klun, Ivan Verdenik, and Špela Smrkolj. "Cancer Stem Cell–Related Marker NANOG Expression in Ovarian Serous Tumors: A Clinicopathological Study of 159 Cases." International Journal of Gynecologic Cancer 27, no. 9 (2017): 2006–13. http://dx.doi.org/10.1097/igc.0000000000001105.

Full text
Abstract:
ObjectiveThe objectives of this study were to assess cancer stem cell–related marker NANOG expression in ovarian serous tumors and to evaluate its prognostic significance in relation to ovarian serous carcinoma.MethodsNANOG protein expression was immunohistochemically evaluated in the ovarian tissue microarrays of 20 patients with benign ovarian serous tumors, 30 patients with borderline ovarian serous tumors, and 109 patients with ovarian serous carcinomas, from which 106 were of high-grade and 3 of low-grade morphology Immunohistochemical reaction was scored according to signal intensity and
APA, Harvard, Vancouver, ISO, and other styles
6

Vaziri Fard, Elmira, Sara Imboden, Tilman Rau, et al. "p53 Abnormal (Copy Number High) Endometrioid Endometrial Carcinoma Has a Prognosis Indistinguishable From Serous Carcinoma." International Journal of Gynecological Pathology 43, no. 5 (2024): 515–26. http://dx.doi.org/10.1097/pgp.0000000000001012.

Full text
Abstract:
Among the 4 molecular subgroups of endometrial carcinoma, the p53 abnormal (copy number high) subgroup has the worst prognosis; however, the histologic characteristics of this subgroup are not well established. Also, it is not well established whether low-grade tumors can belong to the p53 abnormal molecular subgroup and if so, what is the prognostic significance of the p53-mutated molecular subgroup in low-grade tumors. In the current study, we included 146 p53-mutated endometrial carcinomas and performed molecular subgrouping either based on a combination of immunohistochemical studies for p
APA, Harvard, Vancouver, ISO, and other styles
7

Jena, Saubhagya Kumar, Pritinanda Mishra, Vandana Mohapatra, and Sweta Singh. "Bilateral Serous Psammocarcinoma of Ovary: Rare Variant Low Grade Serous Carcinoma." Case Reports in Obstetrics and Gynecology 2015 (2015): 1–4. http://dx.doi.org/10.1155/2015/531242.

Full text
Abstract:
Serous psammocarcinoma is a rare variant of serous carcinoma arising from either ovary or peritoneum, characterized by massive psammoma body formation, low grade cytologic features, and invasiveness. Its clinical behavior is similar to serous borderline tumors with relatively favorable prognosis. We report herein a case of a 60-year-old postmenopausal woman who presented with abdominal distension. Contrast enhanced computed tomography (CECT) revealed calcified pelvic masses with ascites. Elevated serum CA-125 (970 U/mL) suggested malignant ovarian neoplasm. Patient underwent exploratory laparo
APA, Harvard, Vancouver, ISO, and other styles
8

Kimyon Cömert, Günsu, Burak Ersak, Abdurrahman Alp Tokalıoglu, et al. "Prognostic value of the presence of serous endometrial intraepithelial carcinoma in uterine serous carcinoma." Cukurova Medical Journal 49, no. 2 (2024): 239–47. http://dx.doi.org/10.17826/cumj.1392952.

Full text
Abstract:
Purpose: To investigate the clinical-pathological findings, prognosis, and survival outcome of uterine serous carcinoma (USC) with or without serous endometrial intraepithelial carcinoma (SEIC) which is still a rare entity in literature. Materials and Methods: A total of 98 patients with USC who underwent at least a hysterectomy were reviewed. After elimination for exclusion criteria, totally 76 patients with USC who had surgical staging were evaluated. SEIC was defined as the replacement of the surface and glands of the adjacent atrophic endometrium without invasion of the stroma by the highl
APA, Harvard, Vancouver, ISO, and other styles
9

Kalyani, R., Aparna Narasimha, ML Harendra Kumar, and S. Narayanswamy. "Extraovarian Papillary Serous Carcinoma of the Peritoneum: A Report of Two Cases with Review of Literature." Journal of South Asian Federation of Obstetrics and Gynaecology 5, no. 1 (2013): 42–44. http://dx.doi.org/10.5005/jp-journals-10006-1219.

Full text
Abstract:
ABSTRACT Extraovarian papillary serous carcinoma of the peritoneum is a rare malignancy characterized by peritoneal carcinomatosis presenting with abdominal pain and ascites. This tumor is similar to serous ovarian carcinoma in context to its clinical presentation, histologic appearance, pattern of spread, treatment and prognosis. We hereby report two cases of extraovarian papillary serous carcinoma of the peritoneum and review of literature. How to cite this article Kalyani R, Narasimha A, Kumar HML, Narayanswamy S. Extraovarian Papillary Serous Carcinoma of the Peritoneum: A Report of Two Ca
APA, Harvard, Vancouver, ISO, and other styles
10

Sagae, Satoru, Nobuyuki Susumu, Akila N. Viswanathan, et al. "Gynecologic Cancer InterGroup (GCIG) Consensus Review for Uterine Serous Carcinoma." International Journal of Gynecologic Cancer 24, Supp 3 (2014): S83—S89. http://dx.doi.org/10.1097/igc.0000000000000264.

Full text
Abstract:
ObjectivesUterine serous carcinoma (USC) represents a rare and aggressive histologic subtype of endometrial cancer, associated with a poor prognosis. This article critically reviews the literature pertinent to the epidemiology, pathology, molecular biology, diagnosis, management, and perspectives of patients with USC.MethodsAs one of a series of The Gynecologic Cancer InterGroup (GCIG) Rare Tumor Working Group in London, November 2013, we discussed about USC many times with various experts among international GCIG groups.ResultsBoth USC and approximately 25% of high-grade endometrioid tumors r
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Prognosis Serous carcinoma"

1

Cook, Linda S., Angela L. W. Meisner, and Noel S. Weiss. Endometrial Cancer. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0047.

Full text
Abstract:
Endometrial cancer is rare among women of reproductive age, but in older women can occur at an annual rate of up to 50 –100 per 100,000. The incidence varies more than five-fold across regions of the world, with the rates generally being highest in North America and Europe. Endometrial cancer can be classified into two broad histologic groups: the more common type I tumors (e.g., endometrioid adenocarcinoma), which have a relatively good prognosis (case-fatality in the neighborhood of 20%); and the less common type II tumors (e.g., serous carcinoma), which have a poorer prognosis. The endometr
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Prognosis Serous carcinoma"

1

"Prognostic markers of uterine papillary serous carcinoma." In Prognostic and Predictive Factors in Gynecologic Cancers. CRC Press, 2007. http://dx.doi.org/10.3109/9780203089781-19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Chyzhma, Ruslana, and Roman Moskalenko. "PROSPECTS FOR THE USE OF PATHOLOGICAL BIOMINERALIZATION IN THE DIAGNOSIS OF OVARIAN CANCER." In The scientific paradigm in the context of technological development and social change. Publishing House “Baltija Publishing”, 2023. http://dx.doi.org/10.30525/978-9934-26-297-5-27.

Full text
Abstract:
Ovarian cancer is one of the most common causes of death in the female population. Among malignant tumors, ovarian cancer ranks fourth after neoplasms of the body, cervix, and mammary gland. High mortality rates in malignant ovarian neoplasms are primarily due to the asymptomatic course, the ineffectiveness of screening diagnostic methods, and the progression of the tumor process. One of the clinical and morphological features of ovarian cancer is pathological biomineralization. The purpose of the work is to establish the morphological features and phase composition of pathological biominerals
APA, Harvard, Vancouver, ISO, and other styles
3

S. Elhamshary, Ahmed, Mostafa I. Ammar, Eslam Farid Abu Shady, and Ahmed Elnaggar. "Lymph Node Yield and Ratio during Surgery for Advanced Laryngeal Carcinoma." In Lymphatic System - From Human Anatomy to Clinical Practice [Working Title]. IntechOpen, 2023. http://dx.doi.org/10.5772/intechopen.1002887.

Full text
Abstract:
Lymph node metastasis represents one of the most important prognostic factors in patients with head and neck squamous cell carcinomas (HNSCC). Lymph node yield (LNY) is the term used to indicate the total number of dissected lymph nodes following neck dissection, while lymph node ratio (LNR) is the proportion of metastatic lymph nodes to the total number of removed lymph nodes following neck dissection. This ratio serves to determine both the extent of cancer lymphatic spread and the effectiveness of its clearance. Calculating LNY and LNR following neck dissection holds particular significance
APA, Harvard, Vancouver, ISO, and other styles
4

Gogi, Vyshali J., and Vijayalakshmi M. N. "Characterization of Elevated Tumor Markers in Diagnosis of HCC Using Data Mining Methods." In Encyclopedia of Information Science and Technology, Fifth Edition. IGI Global, 2021. http://dx.doi.org/10.4018/978-1-7998-3479-3.ch058.

Full text
Abstract:
Hepatocellular carcinoma (HCC) is an abnormal condition of human liver which is diagnosed at a very advanced stage. The disease is liver disorder which can be predicted after series of clinical and laboratory and imaging studies. Hepatocellular carcinoma is the most malignant tumors which is the major cause of death and requires to be treated at early stage. The prognosis of liver disease is the reflection of both tumor characteristics like tumor size, location and tumor biology along with the degree of underlying resection. Healthcare domain generates huge data which is very complex and vast.
APA, Harvard, Vancouver, ISO, and other styles
5

Shaw, Harsh Kumar, Ayantika Bose, and Debasree Mitra. "LUNGS CANCER DETECTION USING MACHINE LEARNING." In Proceedings of International Conference on Engineering Materials and Sustainable Societal Development [ICEMSSD 2024]. Iterative International Publishers (IIP), Selfypage Developers Pvt Ltd., 2025. https://doi.org/10.58532/nbennuricemssd4.

Full text
Abstract:
Lung cancer stands as one of the foremost lifethreatening cancers worldwide, imposing a significant burden on public health. Timely detection and effective treatment are paramount for patient recovery and improved prognosis. Histopathological analysis, leveraging biopsied tissue samples from potentially afflicted lung regions, remains a cornerstone in the diagnostic process. However, manual interpretation of these histopathological images is often fraught with challenges, including subjectivity, error- proneness, and time-consuming analysis.In response to these challenges, this research endeav
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Prognosis Serous carcinoma"

1

Cui, Shiying, Xinchen Zhang, Xiaotang Yu, et al. "Abstract 5285: miRNA expression pattern for predicting prognosis of ovarian serous carcinoma." In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-5285.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kim, Se Ik, Hee Seung Kim, Hyun Hoon Chung, et al. "Proteomic discovery of plasma protein biomarkers predicting prognosis of high-grade serous ovarian carcinoma." In JSGO 2023. Korean Society of Gynecologic Oncology, 2023. http://dx.doi.org/10.3802/jgo.2023.34.s2.ayd-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Myers, Emily, Lynn K. Tran, Paul M. Tran, et al. "Abstract 2459: Identifying genetic drivers of uterine serous carcinoma patient prognosis with regulatory network analysis." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-2459.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Myers, Emily, Lynn K. Tran, Paul M. Tran, et al. "Abstract 2459: Identifying genetic drivers of uterine serous carcinoma patient prognosis with regulatory network analysis." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-2459.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Lee, Seung Jun, Se Ik Kim, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, and Maria Lee. "EP253/#593 Proteomic discovery of blood biomarkers predicting prognosis of high-grade serous ovarian carcinoma." In IGCS 2022 Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/ijgc-2022-igcs.344.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ow, Ghim Siong, Zhiqun Tang, Anna Vladimirovna Ivshina, and Vladimir Andreevich Kuznetsov. "Abstract A75: Big data and computational biology method for personalized prognosis of high-grade serous ovarian carcinoma." In Abstracts: AACR Special Conference: Advances in Ovarian Cancer Research: Exploiting Vulnerabilities; October 17-20, 2015; Orlando, FL. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1557-3265.ovca15-a75.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Soni, Abhishek, Nupur Bansal, A. K. Dhull, Vivek Kaushal, Rajeev Atri, and Monica Verma. "Diagnostic dilemma of mesonephric adenocarcinoma cervix." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685283.

Full text
Abstract:
Introduction: Mesonephric carcinoma is a rare type of epithelial tumor of the uterine cervix which derive from the remnants of the paired mesonephric (Wolff’s) ducts. The incidence of such neoplasms is difficult to determine due to rarity, previous misclassification of clear cell carcinomas and yolk sac tumours as mesonephric carcinomas and potential underreporting due to misclassification of mesonephric carcinoma as Mullerian tumours or mesonephric hyperplasia. The evidence regarding the clinical course, prognosis and optimal treatment is limited. Materials and Methods: Searches were performe
APA, Harvard, Vancouver, ISO, and other styles
8

Lopes, A., ML Nogueira D Genta, V. da Costa Miranda, RV Mendonza Lopez, F. Marino Carvalho, and J. Paula Carvalho. "94 Histopathological response on clinicoradiological presentation and prognosis of patients with advanced high grade serous ovarian carcinoma treated with neoadjuvant chemotherapy." In IGCS Annual 2019 Meeting Abstracts. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/ijgc-2019-igcs.94.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Tiwari, Alok, Dhananjay Gughe, Radhika Dureja, and Satinder Kaur. "Synchronous primary malignancy of ovary and cervix with different histopathology: A rare case report." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685388.

Full text
Abstract:
Concurrent different histopathological types of gynecologic tumors arise rarely. We present ovarian serous and cervical squamous cell carcinoma formed synchronously. A 51-year-old woman with a poor general condition was admitted with gradual distension of abdomen for 1 year with gradual loss of weight and appetite for the last three months and pain in the abdomen and irregular vaginal bleeding for the last two months. There was no family history of malignancy of genital tract, breast or colon. On examination she was cachexic, pale, dehydrated, tachypnoeic and had edema over feet. Per abdomen e
APA, Harvard, Vancouver, ISO, and other styles
10

Belluco, Rosana Zabulon Feijó, Flávio Lúcio Vasconcelos, Paulo Eduardo Silva Belluco, Júllia Eduarda Feijó Belluco, and Carmelia Matos Santiago Reis. "NIPPLE MINIMUM PAGET DISEASE: A CASE REPORT." In XXIV Congresso Brasileiro de Mastologia. Mastology, 2022. http://dx.doi.org/10.29289/259453942022v32s1059.

Full text
Abstract:
Paget’s disease (PD) of the nipple is a rare cancer that affects the nipple and areola and accounts for between 0.4% and 5% of breast cancers. It was first described in 1877 by the English physician Sir James Paget. It affects women between 60 and 70 years of age and very rarely affects men. In PD, the skin on the nipple and areola becomes thicker. Clinical presentations are usually erythema, desquamation, or eczematous changes in the nipple, features that can progressively progress to erosion, overt destruction, and ulceration of the papilla. Bloody papillary discharge, itching, nipple retrac
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Prognosis Serous carcinoma"

1

Sowjanya, Dr Kaniti, Dr Bongu Srinivas, and Dr Metta Lakshmana Rao. A STUDY ON FIBROSCAN COMPARED TO AST TO PLATELET RATIO INDEX(APRI) FOR ASSESSMENT OF LIVER FIBROSIS WITH NONALCOHOLIC FATTY LIVER DISEASE(NAFLD). World Wide Journals, 2023. http://dx.doi.org/10.36106/ijar/1606016.

Full text
Abstract:
Background : Nonalcoholic fatty liver disease (NAFLD) is increasingly recognized as a cause of chronic liver disease, and often results in the devastating outcomes of decompensated liver cirrhosis and hepatocellular carcinoma and is an important feature of metabolic syndromes and insulin resistance. The assessment of liver brosis is essential for predicting the prognosis and outcome of all forms of chronic liver disease. A liver biopsy is the gold standard for the assessment of liver brosis, but it has its limitations, which include life-threatening complications. Alternative methods of non-
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Prognosis Serous carcinoma' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography